Перейти к основному содержанию
AkademIndex

Продукты

Для разработчиков

AkademBaseОткрытый API экосистемы
← Назад к работе

Работы, на которые ссылается эта работа

Работ: 163

Работа: Microbiome miracles and their pioneering advances and future frontiers in cardiovascular disease

  1. High-performance medicine: the convergence of human and artificial intelligence

    Eric J. Topol

    Обзорная статья2018Цитирований: 10
    ABI
  2. Commensal microbe-derived butyrate induces the differentiation of colonic regulatory T cells

    Yukihiro Furusawa, Yuuki Obata, Shinji Fukuda +27

    Статья2013Цитирований: 5
    ABI
  3. Modified gold and polymeric gold nanostructures: Toxicology and biomedical applications

    Muneeb Ullah, Abdul Wahab, Dilfaraz Khan +4

    Статья2021Цитирований: 5
    ABI
  4. Smart Technologies used as Smart Tools in the Management of Cardiovascular Disease and their Future Perspective

    Muneeb Ullah, Shah Hamayun, Abdul Wahab +9

    Обзорная статья2023Цитирований: 5
    ABI
  5. Stent as a Novel Technology for Coronary Artery Disease and Their Clinical Manifestation

    Muneeb Ullah, Abdul Wahab, Shahid Ullah Khan +9

    Обзорная статья2022Цитирований: 4
    ABI
  6. Shaping the Future of Cardiovascular Disease by 3D Printing Applications in Stent Technology and its Clinical Outcomes

    Muneeb Ullah, Ayisha Bibi, Abdul Wahab +8

    Обзорная статья2023Цитирований: 4
    ABI
  7. Short chain fatty acids in human large intestine, portal, hepatic and venous blood.

    John H. Cummings, E W Pomare, W J Branch +2

    Статья1987Цитирований: 3
    ABI
  8. Role of the Microbiota in Immunity and Inflammation

    Yasmine Belkaid, Timothy W. Hand

    Обзорная статья2014Цитирований: 3
    ABI
  9. An obesity-associated gut microbiome with increased capacity for energy harvest

    Peter J. Turnbaugh, Ruth E. Ley, Michael A. Mahowald +3

    Статья2006Цитирований: 3
    ABI
  10. Are We Really Vastly Outnumbered? Revisiting the Ratio of Bacterial to Host Cells in Humans

    Ron Sender, Shai Fuchs, Ron Milo

    Статья2016Цитирований: 3
    ABI
  11. The Treatment-Naive Microbiome in New-Onset Crohn’s Disease

    Dirk Gevers, Subra Kugathasan, Lee A. Denson +29

    Статья2014Цитирований: 2
    ABI
  12. Are Short Chain Fatty Acids in Gut Microbiota Defensive Players for Inflammation and Atherosclerosis?

    Hideo Ohira, Wao Tsutsui, Yoshio Fujioka

    Обзорная статья2017Цитирований: 2
    ABI
  13. Recent advancements in nanotechnology based drug delivery for the management of cardiovascular disease

    Aziz Ullah, Muneeb Ullah, Sung In Lim

    Статья2024Цитирований: 2
    ABI
  14. Без названия

    ДругоеЦитирований: 2
    ABI
  15. TGR5 Activation Inhibits Atherosclerosis by Reducing Macrophage Inflammation and Lipid Loading

    Thijs W.H. Pols, Mitsunori Nomura, Taoufiq Harach +9

    Статья2011Цитирований: 2
    ABI
  16. Nanotechnology and Biomedical Devices Used as a Novel Tool in Biosensing and Bioimaging of Disease

    Muneeb Ullah, Afraa Waleed, Shah Hamayun +8

    Статья2023Цитирований: 2
    ABI
  17. Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

    Zhan‐Guo Gao, Jun Yin, Jin Zhang +5

    Статья2009Цитирований: 2
    ABI
  18. The gut microbiota as a novel regulator of cardiovascular function and disease

    Micah L. Battson, Dustin M. Lee, Tiffany L. Weir +1

    Обзорная статья2017Цитирований: 2
    ABI